ESR1 and cancer: IFIT1 is frequently upregulated in DNA damage-resistant cancer cell sublines, including those resistant to radiation or chemotherapy [52] and residual tumors following treatment, such as in estrogen receptor–negative breast cancer following chemotherapy [53].